echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Hillicks and Bronger worked together on treatments for rare neurological disorders

    Hillicks and Bronger worked together on treatments for rare neurological disorders

    • Last Update: 2021-03-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    , which is led by artificial intelligence in the UK, is teaming up with Grigg Ingham to identify adaptations associated with rare neurological diseases.
    The two companies will work together on a project that will use helix's AI-based integrated drug discovery platform, the Healy Network, as well as expertise in rare diseases and pharmacology, to identify potential new signs of Bronco's channel assets.
    Mr Hilkes said the company's artificial intelligence platform would play a key role in the partnership and its data analysis and technical capabilities would be used to guide Bronger's priorities for further research.
    Commenting on the partnership, Healy's founder and chief executive, Dr Tim Gilliams, said: "Using the expertise of business intelligence for drug development, particularly in rare neurological diseases, combined with our AI-driven drug discovery platform, will enable the identification of potential new therapies more quickly. No
    the deal has been released. (cyy123.com)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.